MRNS

Marinus Pharmaceuticals, Inc. - Common Stock

$4.36 +$0.06 +1.38%


Own 3 of MRNS at $4.18

Shares Bought3
Shares Sold0
Total3
Shares Owned3
Last Price$4.36
Total Return$0.53
Range Today$4.28 - $4.50
52 Week Range$0.82 - $5.44
Open$4.30
Market Cap$96.40M
Volume/Average776.20K/1.02M
P/E Ratio-
Dividend/Yield-




Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of neuropsychiatric therapeutics. Its clinical stage drug candidate, ganaxolone, is a novel synthetic small molecule that is an analog of allopregnanolone, a natural occurring neurosteriod produced by the human body, which modulates gamma-aminobutyric acid a neurotransmitter in the brain. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.


Orders

Date Side Shares Price
09-11-2017 21:33:12 buy 1 $4.19
09-11-2017 21:44:50 buy 1 $4.18
09-11-2017 21:45:58 buy 1 $4.18